Cassava Sciences Inc (NASDAQ:SAVA)
| 19.72 BATS BZX Real-Time Price As of 12:41pm ET |  +2.24 / +12.81%Today’s Change | 13.84 Today|||52-Week Range 126.51 | -54.87% Year-to-Date |
Latest SAVA News | Press Releases
| Cassava Sciences, Inc. (SAVA) Gains As Market Dips: What You Should Know Jul 26 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 17.48 |
| Today’s open | 17.38 |
| Day’s range | 17.37 - 20.92 |
| Volume | 61,618 |
| Average volume (3 months) | 1,674,697 |
| Market cap | $700.6M |
Data as of 12:41pm ET, 08/08/2022
Growth & Valuation
| Earnings growth (last year) | -238.75% |
| Earnings growth (this year) | -135.37% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.75 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BNGOBionano Genomics Inc | +0.12 | +5.00% |
| ANABAnaptysBio Inc | -1.19 | -4.82% |
| NSTGNanoString Technolog... | -0.50 | -3.24% |
| AGENAgenus Inc | -0.10 | -3.60% |
Data as of 12:41pm ET, 08/08/2022
Financials
| Next reporting date | November 1, 2022 |
| EPS forecast (this quarter) | -$0.48 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$32.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Austin, Texas |
Forecasts
